Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish

Pharmacology Biochemistry and Behavior

Volumn 103, Issue 4, 2013, Pages 792-813

  Irons, T D ^a,b   Kelly, P E ^a   Hunter, D L ^b   MacPhail, R C ^b   Padilla, S ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Acute; Dopamine; Locomotor activity; Receptor; Zebrafish

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; BUTACLAMOL; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; QUINPIROLE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; FERTILIZATION; HYPERACTIVITY; LARVA; LIGHT DARK CYCLE; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; ZEBRA FISH;

ANIMALS; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LARVA; MODELS, ANIMAL; MOTOR ACTIVITY; RECEPTORS, DOPAMINE; ZEBRAFISH;

EID: 84873371376     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.12.010     Document Type: Article

References (71)

1. A. Ames III, and D.A. Pollen Neurotransmission in central nervous tissue: a study of isolated rabbit retina J Neurophysiol 32 1969 424 442
2. T. Archer, T. Palomo, R. McArthur, and A. Fredriksson Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment Neurotox Res 5 2003 95 110
3. P.A. Ardayfio, A. Leung, J. Park, D.Y. Hwang, T. Moran-Gates, and Y.K. Choi Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs Neuroscience 166 2010 391 396
4. R.J. Beninger, E.J. Mazurski, and D.C. Hoffman Receptor subtype-specific dopaminergic agents and unconditioned behavior Pol J Pharmacol Pharm 43 1991 507 528
5. J. Bergman, B.K. Madras, and R.D. Spealman Behavioral effects of D1 and D2 dopaminereceptor antagonists in squirrel monkeys J Pharmacol Exp Ther 258 1991 910 917
6. W. Boehmler, S. Obrecht-Pflumio, V. Canfield, C. Thisse, B. Thisse, and R. Levenson Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish Dev Dyn 230 2004 481 493
7. W. Boehmler, T. Carr, C. Thisse, B. Thisse, V.A. Canfield, and R. Levenson D4 Dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour Genes Brain Behav 6 2007 155 166
8. E. Bowton, C. Saunders, K. Erreger, D. Sakrikar, H.J. Matthies, and N. Sen Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder J Neurosci 30 2010 6048 6057
9. A.R. Braun, and T.N. Chase Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors Eur J Pharmacol 131 1986 301 306
10. H.A. Burgess, and M. Granato Modulation of locomotor activity in larval zebrafish during light adaptation J Exp Biol 210 2007 2526 2539
11. F.P. Bymaster, D.O. Calligaro, J.F. Falcone, R.D. Marsh, N.A. Moore, and N.C. Tye Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology 14 1996 87 96
12. W.Y. Choi, C. Morvan, P.D. Balsam, and J.C. Horvitz Dopamine D1 and D2 antagonist effects on response likelihood and duration Behav Neurosci 123 2009 1279 1287
13. L. Cortese, M.P. Caligiuri, A.K. Malla, R. Manchanda, J. Takhar, and R. Haricharan Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients Schizophr Res 75 2005 65 75
14. P. Drapeau, L. Saint-Amant, R.R. Buss, M. Chong, J.R. McDearmid, and E. Brustein Development of the locomotor network in zebrafish Prog Neurobiol 68 2002 85 111
15. R.S. Dyer, W.E. Howell, and R.C. MacPhail Dopamine depletion slows retinal transmission Exp Neurol 71 1981 326 340
16. F. Emran, J. Rihel, and J.E. Dowling Behavioral assay to measure responsiveness of zebrafish to changes in light increments and decrements J Vis Exp 20 2008 923 10.3791/923
17. T.C. Farrell, C.L. Cario, C. Milanese, A. Vogt, J.H. Jeong, and E.A. Burton Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models Neurobiol Dis 44 2011 9 18
18. A.M. Fernandes, K. Fero, A.B. Arrenberg, S.A. Bergeron, W. Driever, and H.A. Burgess Deep brain photoreceptors control light-seeking behavior in zebrafish larvae Curr Biol 22 2012 2042 2047
19. J.R. Fetcho The utility of zebrafish for studies of the comparative biology of motor systems J Exp Zool B Mol Dev Evol 308 2007 550 562
20. R. Gerlai Zebrafish antipredatory responses: a future for translational research? Behav Brain Res 207 2010 223 231
21. N.J. Giacomini, B. Rose, K. Kobayashi, and S. Guo Antipsychotics produce locomotor impairment in larval zebrafish Neurotoxicol Teratol 28 2006 245 250
22. J.A. Girault, and P. Greengard The neurobiology of dopamine signaling Arch Neurol 61 2004 641 644
23. S. Grillner Neurobiological bases of rhythmic motor acts in vertebrates Science 228 1985 143 149
24. P. Han, S.T. Nakanishi, M.A. Tran, and P.J. Whelan Dopaminergic modulation of spinal neuronal excitability J Neurosci 27 2007 13192 13204
25. D. Herve, C. Le Moine, J.C. Corvol, L. Belluscio, C. Ledent, and A.A. Fienberg Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum J Neurosci 21 2001 4390 4399
26. E.C. Hirsch Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease? Ann Neurol 32 1992 S88 S93 [Suppl.]
27. M.S. Hooks, D.N. Jones, S.G. Holtzman, J.L. Juncos, P.W. Kalivas, and J.B. Justice Jr. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole Psychopharmacology (Berl) 116 1994 217 225
28. J. Hyttel SCH 23390 - the first selective dopamine D-1 antagonist Eur J Pharmacol 91 1983 153 154
29. T.D. Irons, R.C. MacPhail, D.L. Hunter, and S. Padilla Acute neuroactive drug exposures alter locomotor activity in larval zebrafish Neurotoxicol Teratol 32 2010 84 90
30. S.D. Iversen, and L.L. Iversen Dopamine: 50 years in perspective Trends Neurosci 30 2007 188 193
31. R.J. Jensen, and N.W. Daw Towards an understanding of the role of dopamine in the mammalian retina Vision Res 23 1983 1293 1298
32. C. Joselevitch, and M. Kamermans Retinal parallel pathways: seeing with our inner fish Vision Res 49 2009 943 959
33. C. Kimmel Stages of embryonic development of the zebrafish Dev Dyn 203 1995 253 310
34. D.J. King, M. Burke, and R.A. Lucas Antipsychotic drug-induced dysphoria Br J Psychiatry 167 1995 480 482
35. D. Kokel, J. Bryan, C. Laggner, R. White, C.Y. Cheung, and R. Mateus Rapid behavior-based identification of neuroactive small molecules in the zebrafish Nat Chem Biol 6 2010 231 237
36. W. Kolasiewicz, J. Maj, and K. Ossowska The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats J Neural Transm 115 2008 677 681
37. P. Li, S. Shah, L. Huang, A.L. Carr, Y. Gao, and C. Thisse Cloning and spatial and temporal expression of the zebrafish dopamine D1 receptor Dev Dyn 236 2007 1339 1346
38. S.M. Li, G.T. Collins, N.M. Paul, P. Grundt, A.H. Newman, and M. Xu Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rice Behav Pharmacol 21 2010 171 181
39. G. Lynch, D.J. King, J.F. Green, W. Byth, and K. Wilson-Davis The effects of haloperidol on visual search, eye movements and psychomotor performance Psychopharmacology (Berl) 133 1997 233 239
40. R.C. MacPhail, J. Brooks, D.L. Hunter, B. Padnos, T.D. Irons, and S. Padilla Locomotion in larval zebrafish: influence of time of day, lighting and ethanol Neurotoxicology 30 2009 52 58
41. C. Maximino, and A.M. Herculano A review of monoaminergic neuropsychopharmacology in zebrafish Zebrafish 7 2010 359 378
42. L.L. Melo, P. Santos, P. Medeiros, R.O. Mello, E.A. Ferrari, and M.L. Brandao Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy Brain Res 1349 2010 41 47
43. M.J. Millan, L. Maiofiss, D. Cussac, V. Audinot, J.A. Boutin, and A. Newman-Tancredi Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes J Pharmacol Exp Ther 303 2002 791 804
44. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol Rev 78 1998 189 225
45. G.S. Morato, T. Lemos, and R.N. Takahashi Acute exposure to maneb alters some behavioral functions in the mouse Neurotoxicol Teratol 11 1989 421 425
46. A.M. Murray, and J.L. Waddington Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502 Psychopharmacology (Berl) 98 1989 245 250
47. National Research Council Guide for the Care and Use of Laboratory Animals 8th edition 2011 National Academy Press Washington, D.C.
48. J. Nguyen-Legros, C. Versaux-Botteri, and P. Vernier Dopamine receptor localization in the mammalian retina Mol Neurobiol 19 1999 181 204
49. W. Norton, and L. Bally-Cuif Adult zebrafish as a model organism for behavioural genetics BMC Neurosci 11 2010 90
50. J. Obadiah, T. Avidor-Reiss, C.S. Fishburn, S. Carmon, M. Bayewitch, and Z. Vogel Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs Cell Mol Neurobiol 19 1999 653 664
51. C. Oberlander, C. Euvrard, C. Dumont, and J.R. Boissier Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway Eur J Pharmacol 60 1979 163 170
52. P. Panula, V. Sallinen, M. Sundvik, J. Kolehmainen, V. Torkko, and A. Tiittula Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases Zebrafish 3 2006 235 247
53. J. Rihel, D.A. Prober, A. Arvanites, K. Lam, S. Zimmerman, and S. Jang Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation Science 327 2010 348 351
54. E. Rink, and M.F. Wullimann The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum) Brain Res 889 2001 316 330
55. E. Rink, and M.F. Wullimann Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study Brain Res Dev Brain Res 137 2002 89 100
56. L.E. Savio, F.C. Vuaden, A.L. Piato, C.D. Bonan, and A.T. Wyse Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish Prog Neuropsychopharmacol Biol Psychiatry 36 2011 258 263
57. J. Schweitzer, and W. Driever Development of the dopamine systems in zebrafish Adv Exp Med Biol 651 2009 1 14
58. J. Schweitzer, H. Löhr, A. Filippi, and W. Driever Dopaminergic and noradrenergic circuit development in zebrafish Dev Neurobiol 72 2012 256 268
59. K.J. Seibt, A.L. Piato, R. da Luz Oliveira, K.M. Capiotti, M.R. Vianna, and C.D. Bonan Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio) Behav Brain Res 224 2011 135 139
60. E. Shireen, and D.J. Haleem Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats Pak J Pharm Sci 24 2011 7 12
61. S.K. Sobrian, B.L. Jones, S. Varghese, and R.R. Holson Behavioral response profiles following drug challenge with dopamine receptor subtype agonists and antagonists in developing rat Neurotoxicol Teratol 25 2003 311 328
62. B.R. Souza, M.A. Romano-Silva, and V. Tropepe Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae J Neurosci 31 2011 5512 5525
63. T.L. Tay, O. Ronneberger, S. Ryu, R. Nitschke, and W. Driever Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems Nat Commun 2 2011 171
64. V. Tropepe, and H.L. Sive Can zebrafish be used as a model to study the neurodevelopmental causes of autism? Genes Brain Behav 2 2003 268 281
65. U. Ungerstedt 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome Pharmacol Ther B 2 1976 37 40
66. J. Van der Weide, M.E. Tendijck, P.G. Tepper, J.B. De Vries, M.L. Dubocovich, and A.S. Horn The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors Eur J Pharmacol 146 1988 319 326
67. C. Van Hartesveldt, M.E. Meyer, and T.J. Potter Ontogeny of biphasic effects of quinpirole Pharmacol Biochem Behav 48 1994 781 786
68. T. Vitalis, O. Cases, and J.G. Parnavelas Development of the dopaminergic neurons in the rodent brainstem Exp Neurol 191 Suppl. 1 2005 S104 S112
69. K. Voith, and F. Herr The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug Psychopharmacologia 42 1975 11 20
70. C.J. Zeiss Neuroanatomical phenotyping in the mouse: the dopaminergic system Vet Pathol 42 2005 753 773
71. X. Zhuang, L. Belluscio, and R. Hen G(olf)alpha mediates dopamine D1 receptor signaling J Neurosci 20 2000 RC91